A specialized bioreactor based on the principle of simultaneous growth and dialysis permits growth of three-dimensional (3D), multiple-cell-layer osteogenic tissue from isolated osteoblasts over long, continuous-culture intervals (tested up to 10 months with no sign of necrosis). The resulting tissue recapitulates the stages of bone development observed in vivo, including phenotypic maturation of cobblestone-shaped osteoblasts into stellate-shaped osteocytes interconnected by many intercellular processes. Gene expression profiles parallel cell-morphologic changes with time, ultimately leading to increased expression of osteocyte-associated molecules such as E11, DMP1, and sclerostin. Contiguous, cm 2 -scale macroscopic mineral deposits that form within the bioreactor are consistent with bone hydroxyapatite. The simple to use bioreactor system provides an in vitro model that permits the study and manipulation of cancer cell interactions with bone tissue in real time. Metastatic human breast cancer cells, MDA-MB-231 GFP , introduced into the model grow and colonize osteoblastic tissue in a manner reflecting various characteristics of pathologic tissue observed in the clinic. Specifically, MDA-MB-231 GFP cells are observed to penetrate the thick extracellular matrix in which osteoblasts are embedded and to form chains reminiscent of "Indian files," described for infiltrating lobular or metaplastic breast carcinomas. Osteoblasts appear to be marshaled into a parallel alignment with cancer cells, followed by erosion of extracellular matrix structural integrity. Tissue degradation appears to be accompanied by increased expression of osteoblast inflammatory cytokines. [Cancer Res 2009;69(10):4097-100] The skeleton is a favored site for the metastatic spread of breast, prostate, lung, and multiple myeloma cancers (1). Metastasis to the bone often progresses with significant morbidity related to substantial bone loss (osteolytic cancers) or gain (blastic cancers), bone pain, hypercalcemia, pathologic fractures, and spinal cord compression (2). Bone metastasis is particularly pernicious because early-stage detection is obscured by the refractory nature of bone; once bone colonization occurs, the cure rate drops precipitously (1-3). Inaccessibility also hampers a full understanding of the cellular and molecular mechanisms underlying cancer colonization of bone, thereby slowing drug development. Whole animal models are thus too complex for detailed mechanistic studies and, although excised tissue faithfully captures the end stages of bone metastasis associated with fully developed tumors, the critical initial stages of disease remain substantially obscured in this surrogate (4, 5). Standard monolayer cell culture sharply reduces complexity and permits direct access to bone cells; however, in so doing, the biological relevance of a fully developed tissue architecture is lost. For these reasons, as well as for reducing the use of animals for research, three-dimensional (3D) tissue models have become a focus of recent investigation (6, 7) and a challenging target for tissue engineering (8).
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Effective in vitro bone models must strike a difficult balance between experimental efficiency and retention of biological complexity. For example, the metaphysis region of long bone, where cancer cells are known to traffic early in the metastasis process (9) , is chiefly comprised of cancellous bone in the form of thin trabeculae intertwined with blood vessels, connective tissue, and hematopoietic cells of the bone marrow. Trabeculae, in turn, are comprised of a calcified collagenous matrix populated and lined by osteoblasts, which are responsible for bone accretion, interacting with osteoclasts, which are responsible for bone resorption. A minimal model of bone accretion consisting of only osteoblasts must simulate the microenvironment wherein spatially and temporally sequenced secretion of growth factors and cytokines associated with bone development can occur (10) over long periods measured in months. Generally speaking, neither conventional cell culture nor advanced bioreactor systems that rely on scheduled or continuous culture refeeding can reproduce this microenvironment because removal of spent growth medium also eliminates, or significantly perturbs, pericellular concentration gradients.
We have adapted a specific type of bioreactor (11), based on the principle of simultaneous growth and dialysis first pioneered by G.G. Rose (12) , for the purpose of developing an in vitro model of bone with systematically increasing biological complexity (6, 13) . The core idea behind this compartmentalized bioreactor is to continuously feed cells with low-molecular-weight nutrients by dialysis through a cellulose membrane that also retains cellsecreted macromolecules within a cell-growth compartment bounded by this membrane. In this way, metabolic waste products such as lactic acid continuously dialyze out of the cell-growth compartment and into a basal-medium compartment for eventual removal and replacement with fresh growth medium. Growth and feeding functions are thus separated (compartmentalized), and the pericellular space is not perturbed by wholesale growth medium removal. The result is an extraordinarily stable culture environment wherein concentration gradients can develop.
Using this method of culture, we have grown multiple-cell-layer osteogenic tissue from two lines of osteoblasts: human fetal hFOB1.19 (ATCC CRL-11372) and mouse calvaria MC3T3-E1 (ATCC CRL-2593) (ref. 13 ). Focusing on MC3T3-E1-derived tissue, we have observed in vitro the progression of osteoblast development as it occurs in natural bone; i.e., from proliferation and differentiation to engulfment of osteoblasts in a thick cell-secreted mineralized matrix, followed by subsequent phenotypic maturation into a network of osteocytes with a distinctive stellate shape ( Fig. 1A and B) . In some cultures, contiguous, cm 2 -scale macroscopic mineral deposits were formed that proved consistent with bone hydroxyapatite, as shown by X-ray scattering and infrared spectroscopy. In addition, the geneexpression profiles of characteristic osteoblast proteins such as Type 1 collagen, alkaline phosphatase, osteonectin, osteopontin, and osteocalcin mirrored that observed in vivo. After several months, the cultures also expressed molecules indicative of osteocytes, i.e., E11, DMP1, and sclerostin. RNA recovery from these mature cultures was low compared to less mature bioreactors, consistent with decreased cell density (due to apoptosis) and the reduced metabolic activity attributed to osteocytes. To our knowledge, these are the first in vitro observations of massive osteoblast-mediated ossification and phenotypic transformation into osteocytes reported in the literature. The compartmentalized bioreactor thus presents itself as an in vitro model for studies of bone biology and pathology.
The bioreactor is amenable to real-time live-cell analysis by fluorescence confocal microscopy. We have labeled osteoblasts with Cell Tracker Orange, for example, and followed cell morphology over time. At the end of the culture period, the tissue can be fixed, and the cells can be stained for alkaline phosphatase or with phalloidin, and/or labeled with other fluorescent molecule probes (Fig. 1) . Tissue can be further processed by using conventional histologic methods, including conventional light and electron microscopies (13) . We have combined fluorescence with TEM by using fluorescent, electron-dense Quantum Dots (In VitrogenMolecular Probes). Following a protocol similar to that discussed below, we introduced MDA-MB-231 metastatic cancer cells that had internalized Q Tracker 655 dots (10 nm nominal diameter with cadmium cores) into osteoblast cultures and followed cancer cellosteoblast interactions by confocal microscopy before processing the tissue for TEM. The electron-dense dots were observed to collect within perinuclear vacuoles only in the cancer cells and did not transfer to the osteoblasts. In this way, we were able to distinguish cancer cells from osteoblasts and study cell-cell interactions at the TEM level. Finally, all or part of the culture can be released from the membrane for RNA isolation suitable for gene expression by PCR or lysed for protein expression by western blot.
Introduction of MDA-MB-231 GFP human metastatic breast cancer cells (genetically engineered to produce green-fluorescent protein, GFP, and known to invade the murine skeleton 14) onto MC3T3-E1 osteoblastic tissue grown in the compartmentalized bioreactor to various stages of phenotypic maturity allowed us to follow early stages of cancer cell colonization in real time by confocal microscopy ( Fig. 1C-E) . In this way, we observed cancer cell-osteoblast tissue adhesion, cancer cell proliferation, tissue penetration, the formation of nonvascularized microtumors, and the ultimate degradation of osteoblast-derived extracellular matrix (ECM). Cancer cells proliferated and formed into columns of cells that penetrated the collagenous tissue matrix and organized into rows similar to the "Indian files," described for infiltrating lobular or metaplastic breast carcinomas (Fig. 1E and F) (ref. 15) . Migration of cancer cells along tracks of remodeled ECM produced by a preceding invading cell(s) apparently results in characteristic cell-alignment patterns (16) . Invasion by chains of tumor cells linked together by cell-cell contacts is considered to be an effective penetration mechanism (17), conferring high metastatic capacity and commensurately poor prognosis (15, 16) . The observation of filing in the osteoblastic tissue model suggests a considerable degree of physiologic relevance. Indian filing is common in soft tissue, but it is also found in bone metastasis (Fig. 1G-I) .
We also observed an increased expression of inflammatory cytokines such as IL-6 in the presence of the breast cancer cells, as well as a decrease in secretion of soluble (newly formed) collagen and osteocalcin (a marker of osteoblast maturity) (ref. 6). A strong osteoblastic stress response and a decrease in collagen production correlated with the loss of ECM integrity seen after 7 days of coculture with MDA-MB-231 GFP . These results parallel previous studies in conventional culture showing that exposure of osteoblasts to MDA-MB-231 GFP -conditioned medium produced an osteoblastic inflammatory stress response with sharply increased expression of the inflammatory cytokines IL-6, IL-8, and MCP-1 (18) . These cytokines are known to attract and activate osteoclasts, and they are likely to contribute to the tumor-host microenvironment in vivo. In particular, IL-6, a pleiotropic cytokine, has been implicated in the pathogenesis of osteolysis associated with Paget's disease, Gorham-Stout syndrome, and multiple myeloma. IL-6 levels in breast cancer patients have been found to correlate to the clinical stage of the disease as well as to the rate of recurrence. High IL-6 serum levels in breast cancer patients have been found to be an unfavorable prognosis indicator (see [6] and citations therein). IL-8 and the murine-related molecules KC and MIP-2 have also been found to correlate with increased bone metastasis in vivo and with stimulation of osteoclast differentiation followed by bone resorption. Interestingly, MCP-1, a principal chemokine involved in normal bone remodeling, is produced primarily by osteoblasts and not by the metastatic MDA-MB-231 GFP cells upon interaction. Thus, the osteoblastic response to the cancer cells, even in the absence of osteoclasts, changes the tumor microenvironment to favor osteolysis in this particular cancer cell model (6) .
Interestingly, we found that the above-described pattern of cancer colonization was dependent on osteoblastic tissue maturity (Fig. 1B, table portion) . MDA-MB-231 GFP cells failed to penetrate immature osteoblast tissue (less than 30 days in culture), instead forming colonies substantially on, not in, tissue. Significant penetration, remodeling, and characteristic cancer-cell-alignment patterns were observed only in relatively mature osteoblastic tissue. Cancer-cell-induced changes in osteoblast shape and in the production of inflammatory cytokines were seen after as few as 3 days of coculture. We speculate that cancer cell penetration was slowed by close contacts among osteoblasts comprising immature tissue and that it becomes more efficient as the cell/ECM ratio decreases, creating a more permeable tissue.
Comparison of results obtained with tissue grown in the bioreactor to cells grown with conventional tissue culture clearly showed that 3D tissue was superior in modeling details of cancer cell colonization. In the first place, osteoblasts do not grow into more than 1-2 cell layers in conventional cell culture. Furthermore, these cultures usually did not remain healthy for more than about 1 month before showing signs of necrosis or sharply increased apoptosis (13) . These substantially 2D cultures never achieved the phenotypic maturity observed in the bioreactor, and, in particular, there was no evidence of an osteoblast-to-osteocyte transition. In the second place, although the MDA-MB-231 GFP cells proliferated in contact with 2D osteoblast monolayers and formed colonies, these cancer cells did not penetrate the osteoblast monolayers and did not form cell files. It is thus apparent that the 3D osteoblastic tissue model is a better tool for the discovery of therapeutic interventions to cancer colonization of bone. In summary, we have found that the easy to use bioreactor design based on the principle of simultaneous growth and dialysis permitted in vitro culture of 3D, multiple-cell-layer osteoblastic tissue from isolated cells and their maintenance for much longer periods than in conventional culture (demonstrated up to 10 months with no indication of tissue necrosis). This osteoblastic tissue exhibited important hallmarks of the osteoblast-to-osteocyte phenotypic transition and deposition of macroscopic bone. We conclude that the resulting tissue is a relevant in vitro model of osteoblasts within regions of growing bone, such as the metaphysial areas of long bone that are otherwise difficult to access in vivo. Challenge with breast cancer cells known to invade skeleton permitted, for the first time, direct and real-time observation of cancer cell colonization of the osteoblast tissue. Important pathologic events such as cancer cell filing and colony (microtumor) formation observed clinically were reproduced in vitro. These studies have revealed that breast cancer cell colonization strongly depends on osteoblastic tissue maturity, and point to a potentially important point of therapeutic intervention for cancer metastases in bone. Comparison of breast cancer cell interactions with osteoblasts in conventional culture to interactions with osteoblastic tissue in the bioreactor strongly suggested that monolayer cell culture is not the optimal model for studying the cancer cell colonization of bone.
In the future, we plan to use primary osteoblasts (especially human) as source cells for the growth of osteogenic tissue. In addition, we plan to increase the biological complexity of the system by adding other cell types, including osteoclasts. We have already successfully cultured primary osteoblasts isolated from mouse calvaria in the bioreactor. After 3 months, these cells formed a multilayer complex that expressed characteristic osteoblast-differentiation proteins, in a manner similar to that obtained with the pure MC3T-E1 osteoblast cell line. Once we have a human-derived 3D osteogenic tissue model in hand, we plan to study interactions with other metastatic bone cancers (e.g., blastic prostate cancer cells or osteolytic multiple myeloma cells) to determine if human cancer colonization of human osteoblastic tissue parallels pathogenesis in vivo. We intend to explore the development of an in vitro bone-remodeling unit by coculture of primary osteoclasts with osteogenic tissue. Challenging such a mimic with cancer cells should permit the close examination of how cancer cells influence osteoblast-osteoclast interactions and upset normal bone remodeling. Toward the goal of ultimate biological complexity in an in vitro bone model, we aim to recreate the hematopoietic-cancer cell niche by culturing osteoblastic tissue in the presence of mesenchymal stromal cells from bone marrow cells. There is strong evidence in the literature that osteoblasts provide the endosteal niche for hematopoietic stem cells (19) , and that this niche both receives and harbors metastatic cancer cells early in the colonization process. Finally, although this bioreactor system is not an appropriate tool for rapid drug screening, it can serve as an efficient system by which to test therapeutics at a level above that of 2D cell culture but below costly and slow animal testing. Although the described compartmentalized device is not commercially available, engineering plans have been published (11) , and the bioreactor is straightforward enough to make in a standard engineering shop.
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